The PERK pathway: beneficial or detrimental for neurodegenerative diseases and tumor growth and cancer is a research paper published in Human Molecular Genetics (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: NINDS/NS127248
NINDS NIH HHS
Grant: R35 NS127248
FWCI
1.18
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals